PRECLINICAL CHARACTERIZATION OF MOBOCERTINIB HIGHLIGHTS THE PUTATIVE THERAPEUTIC WINDOW OF THIS NOVEL EGFR INHIBITOR TO EGFR EXON 20 INSERTION MUTATIONS

Preclinical Characterization of Mobocertinib Highlights the Putative Therapeutic Window of This Novel EGFR Inhibitor to EGFR Exon 20 Insertion Mutations

Introduction: EGFR exon 20 insertion mutations account for 10% of all EGFR mutations and are mostly insensitive to approved EGFR tyrosine kinase inhibitors (EGFR TKIs).Novel EGFR TKIs have been developed or repurposed for these Animal Toys mutants.A limited number of preclinical studies have detailed these EGFR TKIs.We sought to use commercially av

read more

A multifunctional baicalin-coordinated borate ions/bacterial cellulose composite hydrogel for efficient treatment of chronic wounds

Microbial infection, poor vascular regeneration and abnormal inflammation often impede the smooth repair of skin wounds, and these problems need to be effectively addressed.Baicalin is a natural flavonoid compound with a wide range of beneficial pharmacological effects, including antibacterial, angiogenic and anti-inflammatory properties.However, i

read more